Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy

Int J Cardiol. 2017 Feb 15:229:17-18. doi: 10.1016/j.ijcard.2016.11.265. Epub 2016 Nov 19.

Authors

Affiliations

¹ Department of Medicine, Second Medical Clinic, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: jannis@auth.gr.
² Department of Medicine, Second Medical Clinic, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

PMID: 27887801
DOI: 10.1016/j.ijcard.2016.11.265

No abstract available

Keywords: Cardiovascular disease; Eradication therapy; Fibrinogen; Helicobacter pylori; Metabolic syndrome.

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / prevention & control
Helicobacter Infections / drug therapy*
Helicobacter Infections / epidemiology
Helicobacter Infections / microbiology
Helicobacter pylori / drug effects
Helicobacter pylori / isolation & purification
Humans
Preventive Medicine / methods*
Risk Factors

Substances

Anti-Bacterial Agents